BioXcel Therapeutics
BTAI
BTAI
74 hedge funds and large institutions have $12.5M invested in BioXcel Therapeutics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
52% less capital invested
Capital invested by funds: $26.1M → $12.5M (-$13.6M)
54% less call options, than puts
Call options by funds: $159K | Put options by funds: $346K
Holders
74
Holding in Top 10
–
Calls
$159K
Puts
$346K
Top Buyers
| 1 | +$3.35M | |
| 2 | +$322K | |
| 3 | +$160K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$106K |
| 5 |
Millennium Management
New York
|
+$99.4K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$1.14M | |
| 3 | -$851K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$435K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$370K |